A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma
NCT00002212 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 27
Last updated 2005-06-24
Summary
The purpose of this study is to see if it is safe and effective to give Targretin capsules to patients with AIDS-related Kaposi's sarcoma (KS).
Conditions
- Sarcoma, Kaposi
- HIV Infections
Interventions
- DRUG
-
Bexarotene
Sponsors & Collaborators
-
Ligand Pharmaceuticals
lead INDUSTRY
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment
NCT00005931 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Multicenter Study of Talimogene Laherparepvec in Classic or Endemic Kaposi Sarcoma
NCT04065152 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma
NCT00002259 ·Status: COMPLETED ·Phase: PHASE2
-
Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma
NCT00104949 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma
NCT00002226 ·Status: COMPLETED ·Phase: NA
-
Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma
NCT00019123 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma
NCT02029430 ·Status: COMPLETED ·Phase: PHASE2
-
EMD 121974 in Treating Patients With HIV-Related Kaposi's Sarcoma
NCT00006222 ·Status: TERMINATED ·Phase: PHASE1
-
PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma
NCT00686842 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Antiviral Therapy in Treating Patients With Slowly Progressing HIV-Related Kaposi's Sarcoma
NCT00003419 ·Status: UNKNOWN ·Phase: PHASE2
-
NT-I7 for Kaposi Sarcoma in Patients With or Without HIV
NCT04893018 ·Status: TERMINATED ·Phase: PHASE1
-
SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma
NCT00003720 ·Status: COMPLETED ·Phase: PHASE1
-
Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients
NCT04008238 ·Status: COMPLETED ·Phase: NA
-
BMS-275291 in Treating Patients With HIV-Related Kaposi's Sarcoma
NCT00024024 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma
NCT00000996 ·Status: COMPLETED ·Phase: PHASE2
-
Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary.
NCT00002167 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Classical Non-HIV-Related Kaposi's Sarcoma With the Antiviral Drug Indinavir
NCT00362310 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Selumetinib in Patients With Kaposi's Sarcoma
NCT01752569 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma
NCT00079950 ·Status: SUSPENDED ·Phase: PHASE2
-
Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma
NCT05411237 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients
NCT00002445 ·Status: COMPLETED ·Phase: PHASE3
-
Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma
NCT04941274 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy
NCT00000807 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma
NCT00000660 ·Status: COMPLETED ·Phase: PHASE1
-
An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)
NCT03157167 ·Status: COMPLETED ·Phase: PHASE1